Hims & Hers Health, Inc. (HIMS) stock
HIMSNYSEServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 9/30166% above fair value
$17.05−0.50 (-2.85%)
Close on Nov 18, 2026Market cap $3.98BP/E –Yield –
Hims & Hers Health shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Hims & Hers Health's shares outstanding was 232M at Jun 30, 2026. For fiscal 2025 it was 258M, up 9.0% from the year before. The highest annual figure on record is 258M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 258M | +9.0% |
| FY2024 | Dec 31, 2024 | 237M | +13.1% |
| FY2023 | Dec 31, 2023 | 209M | +2.4% |
| FY2022 | Dec 31, 2022 | 205M | +9.5% |
| FY2021 | Dec 31, 2021 | 187M | +428.3% |
| FY2020 | Dec 31, 2020 | 35M | +1.7% |
| FY2019 | Dec 31, 2019 | 35M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 232M | -9.7% |
| Q1 FY2026 | Mar 31, 2026 | 228M | -7.4% |
| Q4 FY2025 | Dec 31, 2025 | 266M | +7.5% |
| Q3 FY2025 | Sep 30, 2025 | 249M | +5.8% |
| Q2 FY2025 | Jun 30, 2025 | 257M | +9.4% |
| Q1 FY2025 | Mar 31, 2025 | 247M | +7.5% |
| Q4 FY2024 | Dec 31, 2024 | 248M | +17.1% |
| Q3 FY2024 | Sep 30, 2024 | 235M | +11.9% |
| Q2 FY2024 | Jun 30, 2024 | 235M | +12.7% |
| Q1 FY2024 | Mar 31, 2024 | 229M | +10.7% |
| Q4 FY2023 | Dec 31, 2023 | 212M | +2.7% |
| Q3 FY2023 | Sep 30, 2023 | 210M | +2.4% |
| Q2 FY2023 | Jun 30, 2023 | 208M | +2.2% |
| Q1 FY2023 | Mar 31, 2023 | 207M | +2.2% |
| Q4 FY2022 | Dec 31, 2022 | 206M | +2.3% |
| Q3 FY2022 | Sep 30, 2022 | 205M | +2.6% |
| Q2 FY2022 | Jun 30, 2022 | 204M | +6.3% |
| Q1 FY2022 | Mar 31, 2022 | 203M | +32.4% |
| Q4 FY2021 | Dec 31, 2021 | 202M | +469.6% |
| Q3 FY2021 | Sep 30, 2021 | 200M | +461.7% |
| Q2 FY2021 | Jun 30, 2021 | 192M | +443.2% |
| Q1 FY2021 | Mar 31, 2021 | 153M | +342.3% |
| Q4 FY2020 | Dec 31, 2020 | 35M | +603.2% |
| Q3 FY2020 | Sep 30, 2020 | 36M | – |
| Q2 FY2020 | Jun 30, 2020 | 35M | – |
| Q1 FY2020 | Mar 31, 2020 | 35M | – |
| Q2 FY2019 | Jun 30, 2019 | 5M | – |
See a number that looks wrong?